December 2009

Statins do not reduce CV risk in hemodialysis patients

Statins, which are well-established drugs in reducing cardiovascular events in high-risk patients, do not reduce cardiovascular risk in patients undergoing hemodialysis. Patients with chronic kidney disease particularly end-stage renal disease are considered high cardiovascular risk patients.
Investigators conducted a manufacturer-sponsored and administered, international, randomized, double-blind trial of rosuvastatin (10 mg/day) versus placebo in patients aged 50 [...]